Mylan To Buy Sweden's Meda In a $7.2 Billion Deal; Stock Falls After Results
February 10, 2016 at 16:28 PM EST
Mylan N.V. announced Wednesday a deal to buy Swedish specialty pharmaceutical company Meda Aktiebolag in a cash and stock deal valued at the U.S. dollar equivalent of $7.2 billion, or $9.9 billion including debt.
